{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-031087","form_type":"8-K","ticker":"BBIO","cik":"0001743881","company_name":"BridgeBio Pharma, Inc.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.853351+00:00","generated_at":"2026-06-01T02:31:18.316182+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BridgeBio shareholders approve all proposals, including 6.5M share increase to equity plan","bullets":["All five director nominees elected: Eric Aguiar, Jennifer Cook, Andrea Ellis, Fred Hassan, Ali Satvat.","Advisory say-on-pay vote passed with ~134.3M for, ~9.3M against.","Deloitte & Touche ratified as independent auditor for fiscal 2024.","2021 Stock Plan amended to increase shares reserved by 6.5 million.","Broker non-votes were 17.3M on director election and most other proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-031087","json":"https://secwatch.observer/filing/0001140361-24-031087.json","markdown":"https://secwatch.observer/filing/0001140361-24-031087.md","text":"https://secwatch.observer/filing/0001140361-24-031087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/0001140361-24-031087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1743881/000114036124031087/ef20031581_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:31:18.316182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}